Erik Manting's Insider Trades & SAST Disclosures

Erik Manting's most recent trade in TransCode Therapeutics Inc was a trade of 70,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 14, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
TransCode Therapeutics Inc
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2024 70,000 70,000 - - Stock Option (right to buy)
TransCode Therapeutics Inc
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 May 2023 9,500 9,500 - - Stock Option (Right to Buy)
TransCode Therapeutics Inc
Erik Manting Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jun 2022 9,500 9,500 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades